IRD · Opus Genetics Inc. Common Stock
View on chartInsiders & Stakes
| Foundation Fighting Blindness Retinal Degeneration Fund Director | ▼ Sell | Open Market | 3,792,171 Shares held | 5/18/2026 | View profile |
| Cam Gallagher Director | ▲ Buy | Option Exercise | 2,800,111 Shares held | 9/8/2026 | View profile |
| George Magrath Chief Executive Officer | ▼ Sell | Tax Withholding | 2,048,485 Shares held | 9/9/2026 | View profile |
| Benjamin R. Yerxa President | ▼ Sell | Open Market | 704,106 Shares held | 7/23/2026 | View profile |
| Robert E. Gagnon Chief Financial Officer | ▼ Sell | Open Market | 556,375 Shares held | 9/3/2026 | View profile |
| Ashwath Jayagopal Chief Scientific & Dev. Ofc. | ▼ Sell | Open Market | 509,233 Shares held | 4/23/2026 | View profile |
| Sooch Mina President and CEO | ▲ Buy | Grant | 430,501 Shares held | 1/10/2023 | View profile |
| Richard J. Rodgers Director | ▲ Buy | Grant | 343,022 Shares held | 4/20/2026 | View profile |
| Sean Ainsworth | ▲ Buy | Grant | 321,692 Shares held | 4/20/2026 | View profile |
| James S. J. Manuso | ▲ Buy | Grant | 317,318 Shares held | 4/20/2026 | View profile |
| Joseph K. Schachle Chief Operating Officer | ▼ Sell | Open Market | 291,440 Shares held | 7/23/2026 | View profile |
| Jean Bennett | ▲ Buy | Grant | 259,019 Shares held | 4/20/2026 | View profile |
| Susan Benton | ▲ Buy | Grant | 243,894 Shares held | 4/20/2026 | View profile |
| Jhaveri Nirav S. Chief Financial Officer | ▲ Buy | Grant | 194,293 Shares held | 3/13/2025 | View profile |
| Rabourn Amy Zaremba SVP of Finance | ▼ Sell | Open Market | 188,671 Shares held | 4/23/2026 | View profile |
| Hoffmann Bernhard SVP of Corp. Dev. & Ops & Sec. | ▲ Buy | Grant | 185,446 Shares held | 3/13/2025 | View profile |
| Pepose Jay | ▲ Buy | Grant | 180,458 Shares held | 6/11/2024 | View profile |
| Adrienne L. Graves Director | ▲ Buy | Grant | 127,514 Shares held | 4/20/2026 | View profile |
| Patel Ronil A. SVP, Operations & Bus. Dev. | ▼ Sell | Tax Withholding | 90,714 Shares held | 1/10/2024 | View profile |
Transaction History
| George Magrath | ▲ Buy | Option Exercise | 392,157 | $451K | 9/9/2026 |
| George Magrath | ▼ Sell | Tax Withholding | 75,541 | $451K | 9/9/2026 |
| Cam Gallagher | ▲ Buy | Option Exercise | 784,314 | $902K | 9/8/2026 |
| Robert E. Gagnon | ▼ Sell | Open Market | 28,000 | $127K | 9/3/2026 |
| Benjamin R. Yerxa | ▼ Sell | Open Market | 7,429 | $22K | 7/23/2026 |
| Joseph K. Schachle | ▼ Sell | Open Market | 4,644 | $14K | 7/23/2026 |
| George Magrath | ▼ Sell | Open Market | 9,475 | $28K | 7/23/2026 |
| Robert E. Gagnon | ▼ Sell | Open Market | 7,783 | $23K | 7/23/2026 |
| Foundation Fighting Blindness Retinal Degeneration Fund | ▼ Sell | Open Market | 1,700,000 | $7.4M | 5/18/2026 |
| Benjamin R. Yerxa | ▼ Sell | Open Market | 7,470 | $39K | 4/23/2026 |
| Joseph K. Schachle | ▼ Sell | Open Market | 4,697 | $25K | 4/23/2026 |
| Rabourn Amy Zaremba | ▼ Sell | Open Market | 1,641 | $9K | 4/23/2026 |
| George Magrath | ▼ Sell | Open Market | 9,511 | $50K | 4/23/2026 |
| Ashwath Jayagopal | ▼ Sell | Open Market | 7,542 | $39K | 4/23/2026 |
| Robert E. Gagnon | ▼ Sell | Open Market | 7,842 | $41K | 4/23/2026 |
| Richard J. Rodgers | ▲ Buy | Grant | 24,367 | $0 | 4/20/2026 |
| James S. J. Manuso | ▲ Buy | Grant | 24,367 | $0 | 4/20/2026 |
| Adrienne L. Graves | ▲ Buy | Grant | 24,367 | $0 | 4/20/2026 |
| Cam Gallagher | ▲ Buy | Grant | 24,367 | $0 | 4/20/2026 |
| Susan Benton | ▲ Buy | Grant | 24,367 | $0 | 4/20/2026 |
| Jean Bennett | ▲ Buy | Grant | 24,367 | $0 | 4/20/2026 |
| Sean Ainsworth | ▲ Buy | Grant | 24,367 | $0 | 4/20/2026 |
| Joseph K. Schachle | ▼ Sell | Open Market | 3,719 | $20K | 3/16/2026 |
| Rabourn Amy Zaremba | ▼ Sell | Open Market | 2,816 | $15K | 3/16/2026 |
| George Magrath | ▼ Sell | Open Market | 24,438 | $127K | 3/16/2026 |
| Ashwath Jayagopal | ▼ Sell | Open Market | 3,719 | $19K | 3/16/2026 |
| Ashwath Jayagopal | ▼ Sell | Tax Withholding | 5,313 | $18K | 2/12/2026 |
| Benjamin R. Yerxa | ▲ Buy | Grant | 400,000 | $0 | 1/22/2026 |
| Joseph K. Schachle | ▲ Buy | Grant | 250,000 | $0 | 1/22/2026 |
| Rabourn Amy Zaremba | ▲ Buy | Grant | 86,500 | $0 | 1/22/2026 |
| George Magrath | ▲ Buy | Grant | 483,639 | $0 | 1/22/2026 |
| Ashwath Jayagopal | ▲ Buy | Grant | 400,000 | $0 | 1/22/2026 |
| Robert E. Gagnon | ▲ Buy | Grant | 400,000 | $0 | 1/22/2026 |
| Rabourn Amy Zaremba | ▼ Sell | Tax Withholding | 3,390 | $7K | 1/18/2026 |
| Rabourn Amy Zaremba | ▼ Sell | Tax Withholding | 3,950 | $8K | 1/10/2026 |
| Cam Gallagher | ▲ Buy | Grant | 67,000 | $0 | 1/6/2026 |
| James S. J. Manuso | ▲ Buy | Grant | 31,188 | — | 1/1/2026 |
| Adrienne L. Graves | ▲ Buy | Grant | 23,643 | — | 1/1/2026 |
| Jean Bennett | ▲ Buy | Grant | 21,127 | — | 1/1/2026 |
| Sean Ainsworth | ▲ Buy | Grant | 42,507 | — | 1/1/2026 |
| Cam Gallagher | ▲ Buy | Grant | 33,000 | $0 | 12/31/2025 |
| Cam Gallagher | ▲ Buy | Open Market | 81,000 | $160K | 12/29/2025 |
| Cam Gallagher | ▲ Buy | Open Market | 83,000 | $163K | 12/29/2025 |
| Foundation Fighting Blindness Retinal Degeneration Fund | ▼ Sell | Open Market | 4,000,000 | $8.6M | 12/9/2025 |
| George Magrath | ▼ Sell | Tax Withholding | 30,350 | $70K | 11/1/2025 |
| Benjamin R. Yerxa | ▼ Sell | Tax Withholding | 23,795 | $46K | 10/22/2025 |
| Robert E. Gagnon | ▲ Buy | Grant | 200,000 | $0 | 9/10/2025 |
| Sean Ainsworth | ▲ Buy | Grant | 86,956 | $100K | 8/25/2025 |
| Cam Gallagher | ▲ Buy | Grant | 869,565 | $1000K | 8/25/2025 |
| Foundation Fighting Blindness Retinal Degeneration Fund | ▼ Sell | Other | 6,927,419 | — | 5/5/2025 |
| Susan Benton | ▲ Buy | Grant | 79,504 | $0 | 4/30/2025 |
| Cam Gallagher | ▲ Buy | Grant | 79,504 | $0 | 4/30/2025 |
| Richard J. Rodgers | ▲ Buy | Grant | 79,504 | $0 | 4/30/2025 |
| Jean Bennett | ▲ Buy | Grant | 79,504 | $0 | 4/30/2025 |
| Sean Ainsworth | ▲ Buy | Grant | 79,504 | $0 | 4/30/2025 |
| James S. J. Manuso | ▲ Buy | Grant | 79,504 | $0 | 4/30/2025 |
| Adrienne L. Graves | ▲ Buy | Grant | 79,504 | $0 | 4/30/2025 |
| George Magrath | ▲ Buy | Grant | 392,157 | — | 3/24/2025 |
| Cam Gallagher | ▲ Buy | Grant | 784,314 | — | 3/24/2025 |
| Joseph K. Schachle | ▲ Buy | Grant | 52,500 | $0 | 3/13/2025 |
| Rabourn Amy Zaremba | ▲ Buy | Grant | 39,500 | $0 | 3/13/2025 |
| George Magrath | ▲ Buy | Grant | 330,697 | $0 | 3/13/2025 |
| Jhaveri Nirav S. | ▲ Buy | Grant | 52,500 | $0 | 3/13/2025 |
| Ashwath Jayagopal | ▲ Buy | Grant | 52,500 | $0 | 3/13/2025 |
| Hoffmann Bernhard | ▲ Buy | Grant | 29,500 | $0 | 3/13/2025 |
| Jhaveri Nirav S. | ▼ Sell | Tax Withholding | 8,207 | $9K | 2/13/2025 |
| Ashwath Jayagopal | ▼ Sell | Tax Withholding | 5,193 | $6K | 2/13/2025 |
| Rabourn Amy Zaremba | ▼ Sell | Tax Withholding | 8,190 | $9K | 2/4/2025 |
| Hoffmann Bernhard | ▼ Sell | Tax Withholding | 6,751 | $8K | 2/4/2025 |
| Jean Bennett | ▲ Buy | Grant | 34,021 | — | 1/2/2025 |
| James S. J. Manuso | ▲ Buy | Grant | 50,222 | — | 1/2/2025 |
| George Magrath | ▲ Buy | Open Market | 100,000 | $98K | 12/26/2024 |
| George Magrath | ▲ Buy | Grant | 6,200 | $0 | 12/23/2024 |
| Benjamin R. Yerxa | ▲ Buy | Open Market | 10,000 | $10K | 11/21/2024 |
| George Magrath | ▲ Buy | Open Market | 9,706 | $10K | 11/18/2024 |
| George Magrath | ▲ Buy | Open Market | 90,294 | $91K | 11/15/2024 |
| Benjamin R. Yerxa | ▲ Buy | Grant | 332,800 | $0 | 11/7/2024 |
| George Magrath | ▼ Sell | Tax Withholding | 37,050 | $44K | 11/1/2024 |
| Jean Bennett | ▲ Buy | Grant | 100,000 | $0 | 10/22/2024 |
| Pepose Jay | ▲ Buy | Grant | 41,143 | $0 | 6/11/2024 |
| James S. J. Manuso | ▲ Buy | Grant | 41,143 | $0 | 6/11/2024 |
| Susan Benton | ▲ Buy | Grant | 41,143 | $0 | 6/11/2024 |
| Sean Ainsworth | ▲ Buy | Grant | 41,143 | $0 | 6/11/2024 |
| Richard J. Rodgers | ▲ Buy | Grant | 41,143 | $0 | 6/11/2024 |
| Cam Gallagher | ▲ Buy | Grant | 41,143 | $0 | 6/11/2024 |
| Ashwath Jayagopal | ▲ Buy | Open Market | 3,500 | $6K | 5/22/2024 |
| George Magrath | ▲ Buy | Open Market | 5,000 | $9K | 5/17/2024 |
| Pepose Jay | ▲ Buy | Grant | 32,000 | $0 | 4/11/2024 |
| Joseph K. Schachle | ▲ Buy | Open Market | 2,000 | $4K | 3/21/2024 |
| Jhaveri Nirav S. | ▲ Buy | Open Market | 10,000 | $21K | 3/21/2024 |
| George Magrath | ▲ Buy | Open Market | 25,000 | $49K | 3/18/2024 |
| Ashwath Jayagopal | ▲ Buy | Grant | 75,000 | $0 | 2/12/2024 |
| Jhaveri Nirav S. | ▲ Buy | Grant | 140,000 | $0 | 2/12/2024 |
| Rabourn Amy Zaremba | ▲ Buy | Grant | 40,000 | $0 | 1/18/2024 |
| Hoffmann Bernhard | ▲ Buy | Grant | 20,000 | $0 | 1/18/2024 |
| Hoffmann Bernhard | ▼ Sell | Tax Withholding | 4,031 | $13K | 1/10/2024 |
| Rabourn Amy Zaremba | ▼ Sell | Tax Withholding | 3,950 | $13K | 1/10/2024 |
| Patel Ronil A. | ▼ Sell | Tax Withholding | 1,282 | $4K | 1/10/2024 |
| Susan Benton | ▲ Buy | Grant | 19,418 | — | 1/1/2024 |
| Richard J. Rodgers | ▲ Buy | Grant | 24,762 | — | 1/1/2024 |
| James S. J. Manuso | ▲ Buy | Grant | 22,090 | — | 1/1/2024 |
| Pepose Jay | ▲ Buy | Grant | 14,964 | — | 1/1/2024 |
| Patel Ronil A. | ▲ Buy | Grant | 49,692 | $0 | 12/1/2023 |
| Pepose Jay | ▲ Buy | Grant | 35,000 | $0 | 11/1/2023 |
| Richard J. Rodgers | ▲ Buy | Grant | 35,000 | $0 | 11/1/2023 |
| George Magrath | ▲ Buy | Grant | 400,000 | $0 | 11/1/2023 |
| Cam Gallagher | ▲ Buy | Grant | 10,976 | $0 | 6/6/2023 |
| Sean Ainsworth | ▲ Buy | Grant | 10,976 | $0 | 6/6/2023 |
| James S. J. Manuso | ▲ Buy | Grant | 10,976 | $0 | 6/6/2023 |
| Pepose Jay | ▲ Buy | Grant | 10,976 | $0 | 6/6/2023 |
| Susan Benton | ▲ Buy | Grant | 10,976 | $0 | 6/6/2023 |
| Patel Ronil A. | ▲ Buy | Grant | 20,000 | $0 | 4/24/2023 |
| Richard J. Rodgers | ▲ Buy | Grant | 50,000 | $0 | 4/19/2023 |
| Pepose Jay | ▲ Buy | Grant | 468 | — | 4/19/2023 |
| Susan Benton | ▲ Buy | Grant | 1,053 | — | 4/19/2023 |
| James S. J. Manuso | ▲ Buy | Grant | 2,819 | — | 4/19/2023 |
| Pepose Jay | ▲ Buy | Grant | 13,013 | — | 1/11/2023 |
| Richard J. Rodgers | ▲ Buy | Grant | 20,822 | — | 1/11/2023 |
| Susan Benton | ▲ Buy | Grant | 16,267 | — | 1/11/2023 |
| James S. J. Manuso | ▲ Buy | Grant | 18,544 | — | 1/11/2023 |
| Rabourn Amy Zaremba | ▲ Buy | Grant | 46,608 | $0 | 1/10/2023 |
| Hoffmann Bernhard | ▲ Buy | Grant | 46,608 | $0 | 1/10/2023 |
| Sooch Mina | ▲ Buy | Grant | 134,456 | $0 | 1/10/2023 |
| Cam Gallagher | ▼ Sell | Other | 1,574 | $0 | 1/4/2023 |
| Sean Ainsworth | ▼ Sell | Other | 1,574 | $0 | 10/19/2022 |
| James S. J. Manuso | ▼ Sell | Other | 787 | $0 | 10/11/2022 |
| Richard J. Rodgers | ▼ Sell | Other | 3,148 | $0 | 10/3/2022 |
| Sooch Mina | ▼ Sell | Other | 1,023 | $0 | 9/6/2022 |
| Richard J. Rodgers | ▲ Buy | Grant | 7,812 | — | 7/1/2022 |
| Susan Benton | ▲ Buy | Grant | 12,376 | — | 7/1/2022 |
| Richard J. Rodgers | ▲ Buy | Grant | 15,841 | — | 7/1/2022 |
| Pepose Jay | ▲ Buy | Grant | 9,900 | — | 7/1/2022 |
| James S. J. Manuso | ▲ Buy | Grant | 14,108 | — | 7/1/2022 |
| Susan Benton | ▲ Buy | Grant | 6,335 | — | 7/1/2022 |
| Sooch Mina | ▲ Buy | Open Market | 12,500 | $25K | 5/20/2022 |
| James S. J. Manuso | ▲ Buy | Open Market | 5,000 | $10K | 5/20/2022 |
| Sooch Mina | ▲ Buy | Open Market | 12,500 | $26K | 5/19/2022 |
| Susan Benton | ▲ Buy | Grant | 3,395 | — | 4/1/2022 |
| Richard J. Rodgers | ▲ Buy | Grant | 4,629 | — | 4/1/2022 |
| Richard J. Rodgers | ▲ Buy | Grant | 4,021 | — | 1/3/2022 |
| Susan Benton | ▲ Buy | Grant | 2,949 | — | 1/3/2022 |
| Pepose Jay | ▲ Buy | Open Market | 8,250 | $30K | 12/13/2021 |
| James S. J. Manuso | ▲ Buy | Open Market | 2,000 | $7K | 11/18/2021 |
| Richard J. Rodgers | ▲ Buy | Grant | 2,912 | — | 10/1/2021 |
| Susan Benton | ▲ Buy | Grant | 2,135 | — | 10/1/2021 |
| Pepose Jay | ▲ Buy | Open Market | 12,631 | $60K | 9/13/2021 |
| Susan Benton | ▲ Buy | Open Market | 20,000 | $91K | 9/2/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Opus Genetics to Present at Euretina 2026
Opus Genetics announced it will present data at the Euretina 2026 conference. This event is relevant as it provides a platform for the company to share scientific updates on its gene therapy programs. The stock currently trades below the average analyst target price, with a 52-week range spanning from $1.32 to $7.07.
Opus Genetics to Present at Euretina 2026. Opus Genetics announced it will present data at the Euretina 2026 conference. This event is relevant as it provides a platform for the company to share scientific updates on its gene therapy programs. The stock currently trades below the average analyst target price, with a 52-week range spanning from $1.32 to $7.07.